Aclaris Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Aclaris Therapeutics, Inc. (ACRS) had Operating Leases, Future Minimum Payments, Due in Two Years of $1.16 million as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-03-18
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $1.16M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $627.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $627.00K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $394.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $1.16M 10-K · filed 2019-03-18 |
| 2018-03-31 | $627.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $627.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $394.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $363.00K 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |